Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection
Abdulaziz Madani,1 Qais Almuhaideb2 1Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia; 2College of Medicine, King Saud University, Riyadh, Saudi ArabiaCorrespondence: Abdulaziz MadaniKing Saud University, Riyadh, 11451, Saudi ArabiaTel +966 1-80 66481Fax +96...
Saved in:
Main Authors: | Madani A, Almuhaideb Q |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b202cf0fa73d4d00a4effa0fecd8b8b2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
by: Aline Lissa Okita, et al.
Published: (2020) -
Fetal Acrania (Exencephaly) in the Context of a Pregnant Female Taking Adalimumab for Psoriasis: A Case Report
by: Daham N, et al.
Published: (2020) -
FREQUENCY OF CLINICAL FEATURES AND CYTOGENETIC DEFECTS IN DOWN SYNDROME DIAGNOSED AT AFIP
by: Saira Irum, et al.
Published: (2021) -
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience
by: Alvisi P, et al.
Published: (2019) -
Treatment Considerations for Obstructive Sleep Apnea in Pediatric Down Syndrome
by: Erica Gastelum, et al.
Published: (2021)